Skip to content

Comparison of Liagure Safety in Thyroidectomy With Conventional Thyroidectomy

Comparison of Liagure Safety in Thyroidectomy With Conventional Thyroidectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05684536
Enrollment
20
Registered
2023-01-13
Start date
2023-01-15
Completion date
2023-04-01
Last updated
2023-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypocalcemia, Ligature; Hemorrhage, Recurrent Laryngeal Nerve Injuries

Brief summary

To compare intraoperative and postoperative complication rates in thyroidectomy between ligasure and traditional vascular ligation and clipping .

Detailed description

Due to the high vascularity of the thyroid gland and the relatively tiny operative field, rigorous hemostasis is an essential requirement for successful thyroid surgery. Blood vessel ligation and/or ligation are the primary means of attaining hemostasis in thyroidectomy. New technologies have been developed, including a vessel sealing device (ligasure) that seals vessels by fusing the inner layers of the vessel wall with minimal amounts of thermal dispersion burning and tissue friction, thereby minimizing the occurrence of unintentional burns. yet. It is unclear whether the heat conveyed by a ligature can harm the recurrent laryngeal nerve due to its proximity to the berry ligament. thromosis of the inferior parathyroidal gland's supplying artery during dissection may result from alternative prospective delineation of the inferior thyroidal artery using ligasure for dissection. The purpose of this study is to assess the safety and efficacy of ligasure with standard vascular ligation in open thyroid surgery.

Interventions

DEVICEliagsure device

the vessel sealing device ( ligasure covidien ) which seals vessels by fusing the inner layers of the vessel wall, with dissection around ligament of berry and inferior thyroidal artery

Sponsors

Imam Mohammad ibn Saud Islamic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Patient who will undergo lobectomy , subtotal thyroidectomy , total thyroidectomy at time of study Any age \-

Exclusion criteria

* patient undergoing re-do surgery completion thyroidectomy patient undergoing concomitant procedures as cervical lymphadenectomy or parathyroidectomy

Design outcomes

Primary

MeasureTime frameDescription
Post-operative complicationsPostoperatively from day of surgery until one week post operativelyIncluding RLN palsy , hypocalcemia , hemorrhage wound infection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026